# Alora Pharmaceuticals – FDA Inspection, Apr 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/alora-pharmaceuticals/38a374e9-b736-4d83-9e61-6551e192e337
Source feed: FDA_Inspections

> FDA inspection 1312272 of Alora Pharmaceuticals, April 13, 2026. 2 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1312272
- Company Name: Alora Pharmaceuticals
- Inspection Date: 2026-04-13
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1085822 - 2019-03-29](https://www.keypedia.com/records/fda_inspections/alora-pharmaceuticals/c4aa737c-7804-4d1a-805b-ec94a1b10c38)
- FDA Inspection 1048852 - 2017-12-21
- FDA Inspection 1028389 - 2017-09-11
- [FDA Inspection 1014708 - 2017-03-08](https://www.keypedia.com/records/fda_inspections/alora-pharmaceuticals/ac65f52f-03de-4b96-9345-4bca54cd5890)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [Investigator](https://www.keypedia.com/people/samantha-e-cleek/7305f28f-9c92-427d-86ec-42c0bb6bf3ce)
- [FDA Associated Person](https://www.keypedia.com/people/veronica-fuentes/50ea657f-39e6-4d97-a627-86339df3fbe6)

Company: https://www.keypedia.com/companies/alora-pharmaceuticals/cb52e370-b082-4899-a6b3-e88d5a3d3797

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7
